THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Dr. Noshi Ishak, who owns an independent dialysis clinic in Laconia, N.H., says many clinics give Epogen intravenously to get higher payments. ‘‘They do it to milk the system,’’ he said.

Some see profiteering in clinics' use of drug

US may spend $537m needlessly

By Christopher Rowland
Globe Staff / October 24, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

The method most dialysis clinics use to give patients a critical anti-anemia drug may needlessly cost the federal government as much as $537 million annually while generating additional profits for its manufacturer and clinics. (Full article: 1209 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly